Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial-Reference-Cited by-同舟云学术

Efficacy and safety of zotarolimus-eluting and sirolimus-eluting coronary stents in routine clinical care (SORT OUT III): a randomised controlled superiority trial

Published:2010-03 Issue:9720 Volume:375 Page:1090-1099
ISSN:0140-6736
Container-title:The Lancet
language:en
Short-container-title:The Lancet

Author:

Rasmussen Klaus,Maeng Michael,Kaltoft Anne,Thayssen Per,Kelbæk Henning,Tilsted Hans Henrik,Abildgaard Ulrik,Christiansen Evald Høj,Engstrøm Thomas,Krusell Lars Romer,Ravkilde Jan,Hansen Peter Riis,Hansen Knud Nørregaard,Abildstrøm Steen Zabell,Aarøe Jens,Jensen Jan Skov,Kristensen Steen Dalby,Bøtker Hans Erik,Madsen Morten,Johnsen Søren Paaske,Jensen Lisette Okkels,Sørensen Henrik Toft,Thuesen Leif,Lassen Jens Flensted

Publisher

Elsevier BV

Subject

General Medicine

Reference34 articles.

1. Sirolimus-eluting stents versus standard stents in patients with stenosis in a native coronary artery;Moses;N Engl J Med,2003

2. A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease;Stone;N Engl J Med,2004

3. Long-term outcome in patients treated with sirolimus-eluting stents in complex coronary artery lesions: 3-year results of the SCANDSTENT (Stenting Coronary Arteries in Non-Stress/Benestent Disease) trial;Kelbaek;J Am Coll Cardiol,2008

4. 2-year clinical outcomes after implantation of coronary sirolimus-eluting, paclitaxel-eluting, and bare-metal coronary stents: results from the WDHR (Western Denmark Heart Registry);Kaltoft;J Am Coll Cardiol,2009

5. Long-term clinical outcomes after drug-eluting and bare-metal stenting in Massachusetts;Mauri;Circulation,2008

Cited by 180 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Revolutionizing Cardiovascular Frontiers: A Dive Into Cutting-Edge Innovations in Coronary Stent Technology;Cardiology in Review;2024-05-06

2. Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction;Journal of the American College of Cardiology;2023-09

3. Sex Differences in 10-Year Outcomes After Percutaneous Coronary Intervention With Drug-Eluting Stents: Insights From the DECADE Cooperation;Circulation;2023-02-14

4. Five-Year Clinical Outcome of the Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent Compared to the Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention: From the SORT OUT VII Trial;Circulation: Cardiovascular Interventions;2023-01

5. Ten-year patterns of stent thrombosis after percutaneous coronary intervention with new- versus early-generation drug-eluting stents: insights from the DECADE cooperation;Revista Española de Cardiología (English Edition);2022-11